| symbol | subject | date & time | rating |
|
|
Market By PriceBidsTime of OrderSizePrice12:05:4998,0000.080009:30:00160,0000.075009:31:29136,0000.070003:25:06341,0000.065003:25:06210,0000.060003:25:06157,0000.0550AsksPriceSizeTime of Order0.090048,00012:16:150.095032,00012:29:550.100026,00003... |
4/12/2013 12:32:55 PM |
3 |
|
|
Can you please post link to news story! Thanks |
3/22/2013 12:06:10 PM |
|
|
|
Does anyone have a potential rough time line for the Liberian Gov ratification approval process? any insight would be greatly appreciated. |
3/19/2013 11:46:41 PM |
2 |
|
|
NICE reject intravitreal implant for diabetic macular edema Published on December 5, 2012 at 9:15 AM·No Comments By Sarah Guy, medwireNews ReporterThe UK National Institute for Health and Clinical Excellence (NICE) has not recommended a f... |
12/21/2012 8:59:46 AM |
4 |
|
|
http://www.huffingtonpost.com/2012/12/11/visual-impairment-macular-degeneration-diabetic-retinopathy-_n_2278192.html#slide=1154640 Visual Impairment Increasing In U.S. From Macular Degeneration, Diabetic Retinopathy: StudyThe number of people who... |
12/19/2012 9:48:19 PM |
4 |
|
|
Information taken from AlphaStox.comiCo’s 3 Assets You Need to Follow! ALPHASTOX DECEMBER 7, 2012 COMMENTS OFFICO-007: Diabetes Related Blindness Phase II Data around the cornerWe are close to interim Phase II data on 007 and the official we... |
12/14/2012 4:31:49 PM |
4 |
|
|
iCo-007 iCo-007 Click to viewiCo Therapeutics is developing iCo-007, a second generation antisense inhibitor targeting C-raf kinase messenger ribonucleic acid (mRNA), for the treatment of retinal neovascular diseases such as diabetic retinopathy ... |
12/14/2012 4:04:00 PM |
4 |
|
|
Alphastox.com recently published a feature on iCO Therapeutics Inc. enjoy the read Dear Alphastox Subscribers,In these tough market conditions, it is always very important to diversify your holdings. Since March of 2012, the market has been ta... |
12/13/2012 8:59:47 AM |
4 |
|
|
The warrants from the last .45 cent financing have a two year shelf life. The warrants are on a one to one basis which if all the warrants are exercised will generate $3,405,199.00 for the company moving forward. An extra $3.4 million in the ba... |
12/11/2012 11:49:20 AM |
4 |
|
|
www.pivotpointnewswire.com featured company NAN.v is halted pending news at the request of the company IROC: Halt, North American Nickel Inc.12/03/2012 02:38 PM ET VANCOUVER, BRITISH COLUMBIA, Dec 3, 2012 (Marketwire via COMTEX News Network) --... |
12/3/2012 3:13:08 PM |
5 |
|
No additional content to display.
Stockhouse.com: Taking
it to the street
